> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-24/
- Published: 2020-11-15T12:00:00.000Z
- Updated: 2026-09-14T16:36:27.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5147059

[**Oncologic Panel to Review GSK Myeloma BLA**](https://www.fdaweb.com/oncologic-panel-to-review-gsk-myeloma-bla/)  
*Federal Register* notice: FDA announces a 12/14 online/teleconferencing Oncologic Drugs Advisory Committee meeting that will review a GlaxoSmithKline BLA for belantamab mafodotin, indicated for treating certain adults with relapsed or refractory multiple myeloma. 11/13/2020

[**Notice Corrected on ANDAs Withdrawn**](https://www.fdaweb.com/notice-corrected-on-andas-withdrawn/)  
*Federal Register* notice: FDA corrects a 2/12/2020 notice that announced the withdrawal of approval of 12 ANDAs from multiple applicants. 11/12/2020

[**Guide on Patient-Focused Drug Development**](https://www.fdaweb.com/guide-on-patient-focused-drug-development/)  
*Federal Register* notice: FDA makes available a final guidance on “Patient-Focused Drug Development: Collecting Comprehensive and Representative Input.” 11/12/2020

[**Info Collection on Outsourcing Facility Challenges**](https://www.fdaweb.com/info-collection-on-outsourcing-facility-challenges/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for “Obtaining Information to Understand Challenges and Opportunities Encountered by Compounding Outsourcing Facilities.” 11/11/2020

[**Nominations for Compounding Advisory Committee**](https://www.fdaweb.com/nominations-for-compounding-advisory-committee/)  
*Federal Register* notice: FDA requests nominations for members to serve on its Pharmacy Compounding Advisory Committee. 11/10/2020

[**Info Collection on Drug Product Communications**](https://www.fdaweb.com/info-collection-on-drug-product-communications/)  
*Federal Register* notice: FDA seeks comments on an information collection extension entitled “Data To Support Drug Product Communications as Used by the Food and Drug Administration.” 11/09/2020